Paper4636737
A procedure based on statistical criteria for discrimination between steady state kinetic models.
Bártfai T and 1 other. FEBS Lett, 1972. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. A procedure based on statistical criteria for discrimination between steady state kinetic models. Papers, record 4636737. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4636737
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A procedure based on statistical criteria for discrimination between steady state kinetic models.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Enzymes | Major topic |
| Kinetics | Major topic |
| Mathematics | |
| Models, Theoretical |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37445649 | Activation/Inhibition of Cholinesterases by Excess Substrate: Interpretation of the Phenomenological b Factor in Steady-State Rate Equation. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37445649 | PubMed |
| 22247548 | Five decades with glutathione and the GSTome. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22247548 | PubMed |
| 7317034 | Probing the active site of glyoxalase I from human erythrocytes by use of the strong reversible inhibitor S-p-bromobenzylglutathione and metal substitutions. | Biochem J | 1981 | https://conductscience.org/library/papers/7317034 | PubMed |
| 4463963 | A steady-state kinetic model of butyrylcholinesterase from horse plasma. | Biochem J | 1974 | https://conductscience.org/library/papers/4463963 | PubMed |
| 3800965 | A computer program for enzyme kinetics that combines model discrimination, parameter refinement and sequential experimental design. | Biochem J | 1986 | https://conductscience.org/library/papers/3800965 | PubMed |
| 2984330 | In vivo and in vitro studies on the potentiation of muscarinic receptor stimulation by alaproclate, a selective 5-HT uptake blocker. | J Neural Transm | 1985 | https://conductscience.org/library/papers/2984330 | PubMed |
| 810139 | Purification and characterization of two glutathione S-aryltransferase activities from rat liver. | Biochem J | 1975 | https://conductscience.org/library/papers/810139 | PubMed |
| 666725 | What happens when data are fitted to the wrong equation? | Biochem J | 1978 | https://conductscience.org/library/papers/666725 | PubMed |
| 444209 | Multiple inhibition of glutathione S-transferase A from rat liver by glutathione derivatives: kinetic analysis supporting a steady-state random sequential mechanism. | Biochem J | 1979 | https://conductscience.org/library/papers/444209 | PubMed |
| 393249 | Comparison of glyoxalase I purified from yeast (Saccharomyces cerevisiae) with the enzyme from mammalian sources. | Biochem J | 1979 | https://conductscience.org/library/papers/393249 | PubMed |
| 220952 | A steady-state-kinetic model for formaldehyde dehydrogenase from human liver. A mechanism involving NAD+ and the hemimercaptal adduct of glutathione and formaldehyde as substrates and free glutathione as an allosteric activator of the enzyme. | Biochem J | 1979 | https://conductscience.org/library/papers/220952 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4636737
GET https://conductscience.org/api/papers/v1/4636737/authors